Colonoscopy Should Routinely Extend Into the Terminal Ileum - Especially for These Patients

Colonoscopy ends at a junction. Once the endoscope reaches the cecum - the pouch at the beginning of the large intestine - most procedures stop. But a few centimeters further lies the terminal ileum, the final segment of the small intestine, which can harbor disease processes invisible to a procedure that turns back at the ileocecal valve.

Whether to routinely advance the scope into the terminal ileum, and whether to take tissue samples when there, has been a matter of clinical judgment rather than consensus. A systematic review published in Cancer Screening and Prevention now provides the most comprehensive evidence base to date for answering both questions - and the conclusions point clearly toward intubation as a standard step and toward targeted biopsy for specific patient groups.

What the Review Covered

The researchers searched PubMed, EMBASE, Cochrane Library, and the Science Citation Index from January 1971 through October 2025, identifying 36 studies that met inclusion criteria. Case reports, letters, reviews, and animal studies were excluded. Three independent reviewers extracted data. The primary outcomes were the diagnostic yield of terminal ileum intubation - the proportion of cases in which examining the ileum produced a clinically useful finding - and the rate at which those findings changed patient management.

The distinction between selected and unselected patients runs throughout the analysis. Unselected patients are those undergoing colonoscopy for any indication, including routine screening. Selected patients are those with specific symptoms or clinical features that raise suspicion for ileal disease.

The Numbers: Where Ileal Examination Pays Off

Across the 36 studies, the diagnostic yield differed substantially between selected and unselected patients. In unselected patients, terminal ileum intubation produced a clinically relevant finding in 2.5 percent of cases. In selected patients - those with a reason to suspect ileal pathology - that yield rose to 5.1 percent. The rate of findings that required a change in clinical management was 0.4 percent for unselected patients and 1.5 percent for selected patients.

Breaking down the selected-patient data by indication reveals even larger differences. The highest diagnostic yields appeared in patients presenting with inflammatory bowel disease (26.7 percent), anemia (16.1 percent), abdominal pain (14.9 percent), and chronic diarrhea (12.4 percent). For patients undergoing colonoscopy for other indications, the yield dropped to 3.2 percent.

One finding deserves specific attention for its clinical implications: the yield of ileal biopsy in patients with a normal-appearing ileal mucosa was low in both unselected patients (3.5 percent) and selected patients (2.4 percent). This means that when the ileum looks normal to the endoscopist, blind biopsy adds little diagnostic value. The indication for sampling is abnormal mucosal appearance or specific symptomatic context - not routine tissue collection from all patients who undergo intubation.

The Recommendation Structure

The review arrives at a two-tier recommendation. First, terminal ileum intubation should be adopted as standard practice and attempted in all patients undergoing colonoscopy, with photo documentation of the procedure. Second, biopsy should be reserved for patients with abnormal mucosal findings or specific red-flag symptoms: diarrhea, suspected inflammatory bowel disease, abdominal pain, or anemia.

This structure is practically important. Routine intubation adds procedural time and requires technical skill, but it represents a completeness standard for the examination - analogous to reaching the cecum as evidence that the entire colon has been visualized. Biopsy, by contrast, should follow clinical indication rather than become reflexive at the end of every procedure.

Limitations of the Evidence Base

Systematic reviews depend on the quality and consistency of the studies they synthesize. The 54-year range of studies included in this review spans enormous changes in endoscopic technology, sedation practices, and clinical standards - making direct comparisons between older and newer studies difficult. Earlier studies may have used different definitions of diagnostic yield or different criteria for what constitutes a clinically significant finding.

The distinction between selected and unselected patients, while useful, relies on how individual studies defined their patient populations - a classification that varies across institutions and time periods. The management change rate is particularly sensitive to institutional practice patterns and may not reflect current clinical standards in all settings.

No randomized controlled trial has directly compared outcomes between colonoscopy with and without terminal ileum intubation, which means the evidence hierarchy is based on observational data rather than experimental design. That limitation is inherent to the question - it would be difficult to ethically randomize patients to incomplete examination - but it should be acknowledged in interpreting the strength of the recommendations.

Practical Implications

For gastroenterologists, the findings reinforce what many already practice: complete the examination by entering the ileum, document that it was done, and exercise clinical judgment about biopsy based on what is seen and who the patient is. For institutions where terminal ileum intubation rates are low, the review provides a quantitative basis for quality improvement initiatives.

For patients with unexplained chronic diarrhea, suspected inflammatory bowel disease, or unexplained anemia, the data support asking whether ileal examination was completed and whether tissue was sampled - particularly if previous colonoscopies did not include this step.